CN105963188A - 一种含有绞股蓝皂苷的舒敏保湿水及其制备方法 - Google Patents
一种含有绞股蓝皂苷的舒敏保湿水及其制备方法 Download PDFInfo
- Publication number
- CN105963188A CN105963188A CN201610428263.1A CN201610428263A CN105963188A CN 105963188 A CN105963188 A CN 105963188A CN 201610428263 A CN201610428263 A CN 201610428263A CN 105963188 A CN105963188 A CN 105963188A
- Authority
- CN
- China
- Prior art keywords
- parts
- gypenoside
- moisture retention
- water
- shu min
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 239000001397 quillaja saponaria molina bark Substances 0.000 title abstract description 9
- 229930182490 saponin Natural products 0.000 title abstract description 9
- 150000007949 saponins Chemical class 0.000 title abstract description 9
- 240000006509 Gynostemma pentaphyllum Species 0.000 title abstract description 7
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 title abstract description 6
- 206010020751 Hypersensitivity Diseases 0.000 title abstract description 6
- 208000026935 allergic disease Diseases 0.000 title abstract description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 45
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 40
- 239000000284 extract Substances 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 108010039918 Polylysine Proteins 0.000 claims abstract description 24
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims abstract description 21
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 20
- 229960000458 allantoin Drugs 0.000 claims abstract description 20
- 229960003237 betaine Drugs 0.000 claims abstract description 20
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims abstract description 20
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 20
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 19
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000000811 xylitol Substances 0.000 claims abstract description 19
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 19
- 229960002675 xylitol Drugs 0.000 claims abstract description 19
- 235000010447 xylitol Nutrition 0.000 claims abstract description 19
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229930187479 gypenoside Natural products 0.000 claims description 58
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 claims description 58
- 206010016807 Fluid retention Diseases 0.000 claims description 45
- 241000628997 Flos Species 0.000 claims description 29
- 229920001503 Glucan Polymers 0.000 claims description 18
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 14
- 238000007599 discharging Methods 0.000 claims description 7
- 238000009413 insulation Methods 0.000 claims description 7
- 229960004063 propylene glycol Drugs 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 101100381997 Danio rerio tbc1d32 gene Proteins 0.000 claims description 3
- 101100381999 Mus musculus Tbc1d32 gene Proteins 0.000 claims description 3
- 238000007792 addition Methods 0.000 claims description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 239000002537 cosmetic Substances 0.000 abstract description 7
- 230000000638 stimulation Effects 0.000 abstract description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 abstract 1
- 229920002498 Beta-glucan Polymers 0.000 abstract 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 229920002385 Sodium hyaluronate Polymers 0.000 abstract 1
- 229940010747 sodium hyaluronate Drugs 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 14
- 238000012360 testing method Methods 0.000 description 11
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 5
- 230000000172 allergic effect Effects 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 230000002052 anaphylactic effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010051246 Photodermatosis Diseases 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000008845 photoaging Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- UPPXMONNNGGKMB-UHFFFAOYSA-N 3-O-(alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranosyl)spergulagenic acid Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(CO)C(O)C2O)OC2C(C3C(C4C(C5(CCC6(CCC(C)(CC6C5=CC4)C(O)=O)C(O)=O)C)(C)CC3)(C)CC2)(C)C)OC(CO)C(O)C1O UPPXMONNNGGKMB-UHFFFAOYSA-N 0.000 description 1
- 240000005959 Abelmoschus manihot Species 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000001642 Hibiscus manihot Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029098 Neoplasm skin Diseases 0.000 description 1
- 241000223252 Rhodotorula Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000006981 Skin Abnormalities Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010058679 Skin oedema Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 229920000392 Zymosan Polymers 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012009 microbiological test Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000022 skin irritation / corrosion Toxicity 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610428263.1A CN105963188B (zh) | 2016-06-15 | 2016-06-15 | 一种含有绞股蓝皂苷的舒敏保湿水及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610428263.1A CN105963188B (zh) | 2016-06-15 | 2016-06-15 | 一种含有绞股蓝皂苷的舒敏保湿水及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105963188A true CN105963188A (zh) | 2016-09-28 |
CN105963188B CN105963188B (zh) | 2019-02-12 |
Family
ID=57021379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610428263.1A Active CN105963188B (zh) | 2016-06-15 | 2016-06-15 | 一种含有绞股蓝皂苷的舒敏保湿水及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105963188B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018178604A1 (fr) | 2017-03-31 | 2018-10-04 | Jafer | Compositions cosmétiques comprenant une association d'ingrédients et leurs utilisations |
CN108703905A (zh) * | 2018-07-17 | 2018-10-26 | 茗尚品牌管理(上海)有限公司 | 一种皮肤舒缓液及其制备方法 |
CN115414262A (zh) * | 2022-07-19 | 2022-12-02 | 江苏诺兴生物科技有限公司 | 一种ε-聚赖氨酸Pickering乳液及其制备方法和用途 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010105980A (ja) * | 2008-10-31 | 2010-05-13 | Geol Kagaku Kk | クズ澱粉を含有する化粧料 |
CN102860961A (zh) * | 2012-09-24 | 2013-01-09 | 彭再辉 | 一种应用牡丹根提取物的眼膜贴精华液及其制备方法 |
CN103191172A (zh) * | 2012-01-06 | 2013-07-10 | 上海家化联合股份有限公司 | 绞股蓝提取物、其制备方法和应用 |
CN104983651A (zh) * | 2015-08-03 | 2015-10-21 | 广州市华好生物科技有限公司 | 一种向日葵spa柔肤舒缓原液及其制备方法 |
-
2016
- 2016-06-15 CN CN201610428263.1A patent/CN105963188B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010105980A (ja) * | 2008-10-31 | 2010-05-13 | Geol Kagaku Kk | クズ澱粉を含有する化粧料 |
CN103191172A (zh) * | 2012-01-06 | 2013-07-10 | 上海家化联合股份有限公司 | 绞股蓝提取物、其制备方法和应用 |
CN102860961A (zh) * | 2012-09-24 | 2013-01-09 | 彭再辉 | 一种应用牡丹根提取物的眼膜贴精华液及其制备方法 |
CN104983651A (zh) * | 2015-08-03 | 2015-10-21 | 广州市华好生物科技有限公司 | 一种向日葵spa柔肤舒缓原液及其制备方法 |
Non-Patent Citations (3)
Title |
---|
徐虹: "《生物高分子—微生物合成的原理与实践》", 31 May 2010, 化学工业出版社 * |
王建新: "《化妆品植物原料大全》", 30 June 2012, 中国纺织出版社 * |
陈广垠: "《降脂就这么简单》", 31 August 2014, 安徽科学技术出版社 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018178604A1 (fr) | 2017-03-31 | 2018-10-04 | Jafer | Compositions cosmétiques comprenant une association d'ingrédients et leurs utilisations |
FR3064479A1 (fr) * | 2017-03-31 | 2018-10-05 | Jafer Enterprises R&D, S.L.U. | Compositions cosmetiques comprenant une association d'ingredients et leurs utilisations |
CN108703905A (zh) * | 2018-07-17 | 2018-10-26 | 茗尚品牌管理(上海)有限公司 | 一种皮肤舒缓液及其制备方法 |
CN115414262A (zh) * | 2022-07-19 | 2022-12-02 | 江苏诺兴生物科技有限公司 | 一种ε-聚赖氨酸Pickering乳液及其制备方法和用途 |
CN115414262B (zh) * | 2022-07-19 | 2023-09-22 | 江苏诺兴生物科技有限公司 | 一种ε-聚赖氨酸Pickering乳液及其制备方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
CN105963188B (zh) | 2019-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101700218B (zh) | 一种美白保湿滋养凝胶及其制备方法 | |
CN105395467B (zh) | 一种中药组合物、美肤化妆品及其应用 | |
CN107080716A (zh) | 石斛修护多效面膜及其制作方法 | |
CN102716511B (zh) | 一种抗菌、低敏喷剂 | |
CN105106655B (zh) | 一种修复性烧伤烫伤膏及其制备方法 | |
KR102700722B1 (ko) | 완화 복구용 조성물 및 그 제조 방법과 응용 | |
CN113521164B (zh) | 一种具有抑菌作用的藏药组合物及其制备方法和应用 | |
CN107308014A (zh) | 一种增稠悬浮组合物及其应用 | |
CN105963188A (zh) | 一种含有绞股蓝皂苷的舒敏保湿水及其制备方法 | |
CN108498390A (zh) | 一种治疗痤疮的藏本草提取物及其制备方法与应用 | |
CN103202786B (zh) | 一种具有去头屑功能的中药组合物提取物及其在化妆品中的应用 | |
CN113398237A (zh) | 一种抗菌止痒止屑的中药组合物及其制备方法 | |
KR20070014988A (ko) | 아토피성 피부용 화장료 조성물 | |
CN101836920A (zh) | 一种远红外线活氧负离子卫生巾及保健垫 | |
CN108703911B (zh) | 一种具有保湿美白功效的组合物及其制备方法和应用 | |
CN107569417A (zh) | 中老年人用护肤止痒乳液及其制备方法 | |
KR20160043430A (ko) | 탈모 예방 또는 발모 촉진, 또는 모발의 보윤·보습용 조성물 및 이의 제조방법 | |
CN106466261B (zh) | 养生护肤组合物 | |
CN108078868A (zh) | 一种用于护肤品的抗过敏组合物 | |
KR102293585B1 (ko) | 왁스형 클렌저 | |
CN104053425A (zh) | 基于胶体银和脱氧核糖核酸的协同组合的医学护肤组合物 | |
CN108677530B (zh) | 抗菌整理剂及其制备方法和应用 | |
TWI653989B (zh) | 包含藉由東方草藥加工所獲得的草藥萃取物之組成物 | |
CN105194286B (zh) | 具有防辐射及修复皮肤屏障功效的外用护肤组合物、精华素及其制备方法 | |
CN103655304A (zh) | 一种含海洋生物成分的祛斑软膜及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231018 Address after: 102, Building 1, No. 76, Xieshi Road, Shibi Street, Shibi Village, Panyu District, Guangzhou City, Guangdong Province, 510000 Patentee after: Guangdong Kewei Zhili Biopharmaceutical Co.,Ltd. Address before: Room 301 and 401, No. 39 Baoying Avenue, Guangzhou Free Trade Zone, Guangdong Province, 510070 Patentee before: GUANGDONG COOWAY BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: Room 501, No. 39 Baoying Avenue, Huangpu District, Guangzhou City, Guangdong Province, 510700 Patentee after: Guangdong Zhili Biopharmaceutical Co.,Ltd. Country or region after: China Address before: 102, Building 1, No. 76, Xieshi Road, Shibi Street, Shibi Village, Panyu District, Guangzhou City, Guangdong Province, 510000 Patentee before: Guangdong Kewei Zhili Biopharmaceutical Co.,Ltd. Country or region before: China |